This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean Intraocular Pressure at each timepoint post-randomization
Timeframe: Week 2, Week 6, Month 3 at 08:00, 10:00, 16:00 hours